Citigroup’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,762
| Closed | -$45K | – | 7772 |
|
|
2020
Q3 | $45K | Sell |
4,762
-23,867
| -83% | -$227K | ﹤0.01% | 5676 |
|
|
2020
Q2 | $219K | Sell |
28,629
-16,441
| -36% | -$126K | ﹤0.01% | 4949 |
|
|
2020
Q1 | $279K | Sell |
45,070
-18,017
| -29% | -$159K | ﹤0.01% | 4436 |
|
|
2019
Q4 | $768K | Sell |
63,087
-25,175
| -29% | -$275K | ﹤0.01% | 4032 |
|
|
2019
Q3 | $1.02M | Buy |
88,262
+70,599
| +400% | +$743K | ﹤0.01% | 3628 |
|
|
2019
Q2 | $177K | Sell |
17,663
-5,747
| -25% | -$62K | ﹤0.01% | 5367 |
|
|
2019
Q1 | $301K | Sell |
23,410
-289,482
| -93% | -$4.31M | ﹤0.01% | 4706 |
|
|
2018
Q4 | $4.75M | Buy |
312,892
+296,682
| +1,830% | +$5.65M | ﹤0.01% | 1856 |
|
|
2018
Q3 | $324K | Buy |
16,210
+14,104
| +670% | +$321K | ﹤0.01% | 4758 |
|
|
2018
Q2 | $41K | Sell |
2,106
-13,872
| -87% | -$307K | ﹤0.01% | 6441 |
|
|
2018
Q1 | $321K | Sell |
15,978
-89,696
| -85% | -$1.52M | ﹤0.01% | 4459 |
|
|
2017
Q4 | $1.4M | Buy |
105,674
+25,646
| +32% | +$387K | ﹤0.01% | 3003 |
|
|
2017
Q3 | $1.48M | Sell |
80,028
-60,512
| -43% | -$1.13M | ﹤0.01% | 2970 |
|
|
2017
Q2 | $2.59M | Buy |
140,540
+44,504
| +46% | +$882K | ﹤0.01% | 2330 |
|
|
2017
Q1 | $2.17M | Sell |
96,036
-128,707
| -57% | -$3.08M | ﹤0.01% | 2403 |
|
|
2016
Q4 | $7.82M | Buy |
224,743
+194,250
| +637% | +$5.8M | 0.01% | 1387 |
|
|
2016
Q3 | $747K | Buy |
30,493
+22,291
| +272% | +$557K | ﹤0.01% | 3519 |
|
|
2016
Q2 | $197K | Sell |
8,202
-17,096
| -68% | -$392K | ﹤0.01% | 4514 |
|
|
2016
Q1 | $593K | Buy |
25,298
+16,202
| +178% | +$385K | ﹤0.01% | 3943 |
|
|
2015
Q4 | $276K | Sell |
9,096
-8,025
| -47% | -$259K | ﹤0.01% | 4447 |
|
|
2015
Q3 | $680K | Buy |
17,121
+6,481
| +61% | +$402K | ﹤0.01% | 3452 |
|
|
2015
Q2 | $735K | Sell |
10,640
-2,677
| -20% | -$168K | ﹤0.01% | 3372 |
|
|
2015
Q1 | $728K | Buy |
13,317
+681
| +5% | +$32.5K | ﹤0.01% | 3381 |
|
|
2014
Q4 | $539K | Buy |
12,636
+11,623
| +1,147% | +$420K | ﹤0.01% | 3811 |
|
|
2014
Q3 | $32K | Sell |
1,013
-3,478
| -77% | -$74.2K | ﹤0.01% | 5604 |
|
|
2014
Q2 | $93K | Sell |
4,491
-7,171
| -61% | -$133K | ﹤0.01% | 4726 |
|
|
2014
Q1 | $226K | Buy |
11,662
+2,919
| +33% | +$62K | ﹤0.01% | 4212 |
|
|
2013
Q4 | $212K | Buy |
8,743
+4,086
| +88% | +$96.1K | ﹤0.01% | 4606 |
|
|
2013
Q3 | $100K | Buy |
4,657
+4,372
| +1,534% | +$103K | ﹤0.01% | 4721 |
|
|
2013
Q2 | $7K | Buy |
+285
| New | +$6.28K | ﹤0.01% | 6237 |
|
Citigroup's AMAG Position: Q4 2020 in Review
Citigroup sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 4,762 shares — an estimated $45K sold.
Citigroup first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $7.82M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Citigroup reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Citigroup sold 4,762 AMAG Pharmaceuticals shares in Q4 2020, an estimated $45K.
- Citigroup first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Citigroup's AMAG Pharmaceuticals position peaked at $7.82M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.